Comparison of Pharmacokinetics and Safety of Ranolazine PR between Koreans and Caucasians.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2021.01.005
Abstract: PURPOSE Ranolazine, an inhibitor of late inward sodium current, is an antianginal agent. In this study, the pharmacokinetic (PK) properties and tolerability of single- and multiple-dose ranolazine were compared between healthy Koreans and Caucasians. METHODS… read more here.
Keywords: ranolazine; difference; koreans caucasians; safety ... See more keywords